Folate and phototherapy: What should we inform our patients?


      Ultraviolet (UV) degradation of folate has been studied in vitro and in vivo, but comprehensive reviews of the subject and recommendations for supplementing folate are lacking, especially for women of childbearing age, in whom decreases in folate predisposes newborns to neural tube defects.


      We reviewed the effects of phototherapy on folate and provide a recommendation for women of childbearing age on phototherapy.


      PubMed was searched for in vivo studies comparing folate levels before and after phototherapy.


      There is no evidence of decreased folate levels after UVA exposure. Decreased folate levels after sun exposure were limited to subjects taking folate supplements. Studies using narrowband UVB showed mixed results, potentially explained by dose-dependent degradation of folate; exposure >40 J/cm2 cumulatively and >2 J/cm2 per treatment were associated with 19%-27% decreases in serum folate levels, while lower doses did not affect folate levels.


      Extensive variability in results from studies and lack of considering confounders.


      We recommend all women of childbearing age on phototherapy take 0.8 mg/day of folate supplements, as suggested by current guidelines for women of childbearing age, to reduce the risk of neural tube defects in unplanned pregnancy.

      Key words

      Abbreviations used:

      5MTHF (5-methyltetrahydrofolate), NB (narrowband), NTD (neural tube defect), PTB (per ten thousand births), PUVA (psoralen plus ultraviolet A), UV (ultraviolet)
      To read this article in full you will need to make a payment
      AAD Member Login
      AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Menter A.
        • Korman N.J.
        • Elmets C.A.
        • et al.
        Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy.
        J Am Acad Dermatol. Jan 2010; 62: 114-135
        • Whitton M.E.
        • Pinart M.
        • Batchelor J.
        • et al.
        Interventions for vitiligo.
        Cochrane Database Syst Rev. 2015; : Cd003263
        • Olsen E.A.
        • Hodak E.
        • Anderson T.
        • et al.
        Guidelines for phototherapy of mycosis fungoides and Sezary syndrome: a consensus statement of the United States Cutaneous Lymphoma Consortium.
        J Am Acad Dermatol. Jan 2016; 74: 27-58
        • Meduri N.B.
        • Vandergriff T.
        • Rasmussen H.
        • Jacobe H.
        Phototherapy in the management of atopic dermatitis: a systematic review.
        Photodermatol Photoimmunol Photomed. Aug 2007; 23: 106-112
        • MRC Vitamin Study Research Group
        Prevention of neural tube defects: results of the Medical Research Council Vitamin Study.
        Lancet. 1991; 338: 131-137
        • Czeizel A.E.
        • Dudas I.
        Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.
        N Engl J Med. 1992; 327: 1832-1835
        • Hernandez-Diaz S.
        • Werler M.M.
        • Walker A.M.
        • Mitchell A.A.
        Folic acid antagonists during pregnancy and the risk of birth defects.
        N Engl J Med. 2000; 343: 1608-1614
        • Murase J.E.
        • Koo J.Y.
        • Berger T.G.
        Narrowband ultraviolet B phototherapy influences serum folate levels in patients with vitiligo.
        J Am Acad Dermatol. 2010; 62: 710-711
        • Park K.K.
        • Murase J.E.
        Narrowband UV-B phototherapy during pregnancy and folic acid depletion.
        Arch Dermatol. Jan 2012; 148: 132-133
        • Lucock M.
        Folic acid: nutritional biochemistry, molecular biology, and role in disease processes.
        Mol Genet Metab. 2000; 71: 121-138
        • Pietrzik K.
        • Bailey L.
        • Shane B.
        Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics.
        Clin Pharmacokinet. Aug 2010; 49: 535-548
        • Stokstad E.L.
        • Fordham D.
        • De G.A.
        The inactivation of pteroylglutamic acid (liver Lactobacillus casei factor) by light.
        J Biol Chem. Mar 1947; 167: 877
        • Branda R.F.
        • Eaton J.W.
        Skin color and nutrient photolysis: an evolutionary hypothesis.
        Science. 1978; 201: 625-626
        • Steindal A.H.
        • Juzeniene A.
        • Johnsson A.
        • Moan J.
        Photodegradation of 5-methyltetrahydrofolate: biophysical aspects.
        Photochem Photobiol. 2006; 82: 1651-1655
        • Steindal A.H.
        • Tam T.T.
        • Lu X.Y.
        • Juzeniene A.
        • Moan J.
        5-Methyltetrahydrofolate is photosensitive in the presence of riboflavin.
        Photochem Photobiol Sci. Jul 2008; 7: 814-818
        • Tam T.T.
        • Juzeniene A.
        • Steindal A.H.
        • Iani V.
        • Moan J.
        Photodegradation of 5-methyltetrahydrofolate in the presence of uroporphyrin.
        J Photochem Photobiol B. 2009; 94: 201-204
        • Akhtar M.J.
        • Khan M.A.
        • Ahmad I.
        Photodegradation of folic acid in aqueous solution.
        J Pharm Biomed Anal. Mar 1999; 19: 269-275
        • Off M.K.
        • Steindal A.E.
        • Porojnicu A.C.
        • et al.
        Ultraviolet photodegradation of folic acid.
        J Photochem Photobiol B. 2005; 80: 47-55
        • Juzeniene A.
        • Thu Tam T.T.
        • Iani V.
        • Moan J.
        The action spectrum for folic acid photodegradation in aqueous solutions.
        J Photochem Photobiol B. 2013; 126: 11-16
        • Gambichler T.
        • Bader A.
        • Sauermann K.
        • Altmeyer P.
        • Hoffmann K.
        Serum folate levels after UVA exposure: a two-group parallel randomised controlled trial.
        BMC Dermatol. 2001; 1: 8
        • Der-Petrossian M.
        • Fodinger M.
        • Knobler R.
        • Honigsmann H.
        • Trautinger F.
        Photodegradation of folic acid during extracorporeal photopheresis.
        Br J Dermatol. Jan 2007; 156: 117-121
        • Shaheen M.
        • Fattah N.A.
        • El-Borhamy M.
        Analysis of serum folate levels after narrow band UVB exposure.
        Egypt Dermatol Online J. 2006; 2: 1-7
        • El-Saie L.T.
        • Rabie A.R.
        • Kamel M.I.
        • Seddeik A.K.
        • Elsaie M.L.
        Effect of narrowband ultraviolet B phototherapy on serum folic acid levels in patients with psoriasis.
        Lasers Med Sci. Jul 2011; 26: 481-485
        • Rose R.F.
        • Batchelor R.J.
        • Turner D.
        • Goulden V.
        Narrowband ultraviolet B phototherapy does not influence serum and red cell folate levels in patients with psoriasis.
        J Am Acad Dermatol. Aug 2009; 61: 259-262
        • Cicarma E.
        • Mork C.
        • Porojnicu A.C.
        • et al.
        Influence of narrowband UVB phototherapy on vitamin D and folate status.
        Exp Dermatol. Aug 2010; 19: e67-72
        • Magina S.
        • Cruz M.J.
        • Azevedo F.
        • Moura D.
        • Moura E.
        • Vieira-Coelho M.A.
        Narrowband ultraviolet B treatment for psoriasis increases serum vitamin A levels.
        Br J Dermatol. Oct 2012; 167: 958-960
        • Atas H.
        • Cemil B.C.
        • Gonul M.
        • Basturk E.
        • Cicek E.
        Serum levels of homocysteine, folate, and vitamin B12 in patients with vitiligo before and after treatment with narrow band ultraviolet B phototherapy and in a group of controls.
        J Photochem Photobiol B. Jul 2015; 148: 174-180
        • Brenner M.
        • Hearing V.J.
        The protective role of melanin against UV damage in human skin.
        Photochem Photobiol. 2008; 84: 539-549
        • Anderson R.R.
        • Parrish J.A.
        The optics of human skin.
        J Invest Dermatol. Jul 1981; 77: 13-19
        • Romani J.
        • Caixas A.
        • Carrascosa J.M.
        • Ribera M.
        • Rigla M.
        • Luelmo J.
        Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis.
        Br J Dermatol. 2012; 166: 1237-1244
        • Fukuwatari T.
        • Fujita M.
        • Shibata K.
        Effects of UVA irradiation on the concentration of folate in human blood.
        Biosci Biotechnol Biochem. 2009; 73: 322-327
        • Borradale D.
        • Isenring E.
        • Hacker E.
        • Kimlin M.G.
        Exposure to solar ultraviolet radiation is associated with a decreased folate status in women of childbearing age.
        J Photochem Photobiol B. 2014; 131: 90-95
        • Osmancevic A.
        • Nilsen L.T.
        • Landin-Wilhelmsen K.
        • et al.
        Effect of climate therapy at Gran Canaria on vitamin D production, blood glucose, and lipids in patients with psoriasis.
        J Eur Acad Dermatol Venereol. Oct 2009; 23: 1133-1140
        • Juzeniene A.
        • Stokke K.T.
        • Thune P.
        • Moan J.
        Pilot study of folate status in healthy volunteers and in patients with psoriasis before and after UV exposure.
        J Photochem Photobiol B. 2010; 101: 111-116
        • McDonnell R.J.
        • Johnson Z.
        • Delaney V.
        • Dack P.
        East Ireland 1980-1994: epidemiology of neural tube defects.
        J Epidemiol Community Health. 1999; 53: 782-788
        • Obeidat A.Z.
        • Amarin Z.
        Neural tube defects in the north of Jordan: is there a seasonal variation?.
        J Child Neurol. Jul 2010; 25: 864-866
        • Giardini V.
        • Russo F.M.
        • Ornaghi S.
        • Todyrenchuk L.
        • Vergani P.
        Seasonal impact in the frequency of isolated spina bifida.
        Prenat Diagn. Oct 2013; 33: 1007-1009
        • Beyer D.A.
        • Diedrich K.
        • Weichert J.
        • Kavallaris A.
        • Amari F.
        Seasonality of spina bifida in Northern Germany.
        Arch Gynecol Obstet. Oct 2011; 284: 849-854
        • Siffel C.
        • Alverson C.J.
        • Correa A.
        Analysis of seasonal variation of birth defects in Atlanta.
        Birth Defects Res A Clin Mol Teratol. Oct 2005; 73: 655-662
        • Zaganjor I.
        • Sekkarie A.
        • Tsang B.L.
        • et al.
        Describing the prevalence of neural tube defects worldwide: a systematic literature review.
        PLoS One. 2016; 11: e0151586
        • Hao L.
        • Ma J.
        • Stampfer M.J.
        • et al.
        Geographical, seasonal, and gender differences in folate status among Chinese adults.
        J Nutr. 2003; 133: 3630-3635
        • Snow C.F.
        Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician.
        Arch Intern Med. 1999; 159: 1289-1298
        • Antony A.
        Megaloblastic anemias.
        in: Hoffman R. Edward B. Silberstein L. Heslop H. Weitz J. Anastasi J. Hematology: Basic principles and practice. 4th ed. Churchill Livingstone, New York2005
        • Wald N.J.
        • Law M.R.
        • Morris J.K.
        • Wald D.S.
        Quantifying the effect of folic acid.
        Lancet. 2001; 358: 2069-2073
        • Grimes D.A.
        Unplanned pregnancies in the United States.
        Obstet Gynecol. Mar 1986; 67: 438-442
        • Cheschier N.
        • ACOG Committee on Practice Bulletins-Obstetrics
        ACOG practice bulletin. Neural tube defects. Number 44, July 2003. (Replaces committee opinion number 252, March 2001).
        Int J Gynaecol Obstet. Oct 2003; 83: 123-133
        • US Preventive Services Task Force
        Folic acid for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement.
        Ann Intern Med. 2009; 150: 626-631
        • Tinker S.C.
        • Hamner H.C.
        • Qi Y.P.
        • Crider K.S.
        US women of childbearing age who are at possible increased risk of a neural tube defect–affected pregnancy due to suboptimal red blood cell folate concentrations, National Health and Nutrition Examination Survey 2007 to 2012.
        Birth Defects Res A Clin Mol Teratol. 2015; 103: 517-526
        • Vatanavicharn S.
        • Anuvatanakulchai M.
        • Na-Nakorn S.
        • Wasi P.
        Serum erythrocyte folate levels in thalassaemic patients in Thailand.
        Scand J Haematol. Mar 1979; 22: 241-245
        • Lindenbaum J.
        • Klipstein F.A.
        Folic acid deficiency in sickle-cell anemia.
        N Engl J Med. 1963; 269: 875-882
        • Lambie D.G.
        • Johnson R.H.
        Drugs and folate metabolism.
        Drugs. Aug 1985; 30: 145-155
      1. Folate status in women of childbearing age, by race/ethnicity–United States, 1999-2000.
        MMWR Morb Mortal Wkly Rep. 2002; 51: 808-810
        • Steijns L.S.
        • Braams-Wiatrowska J.K.
        • Luiting H.J.
        • van der Weide J.
        Evaluation of nonisotopic binding assays for measuring vitamin B12 and folate in serum.
        Clin Chim Acta. 1996; 248: 135-141
        • van den Berg H.
        • Finglas P.M.
        • Bates C.
        FLAIR intercomparisons on serum and red cell folate.
        Int J Vitam Nutr Res. 1994; 64: 288-293